Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
Pending Committee Action in House of Origin
Email me when HB 127 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 127. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill stops the Alabama Board of Pharmacy, pharmacy employers, and pharmacy benefit managers from revoking, suspending, or otherwise penalizing pharmacists who suggest or fill off‑label prescriptions. It also lets anyone buy ivermectin and hydroxychloroquine over the counter, while keeping existing rules for controlled substances and untested off‑label uses. The change aims to give pharmacists the same legal protection physicians already have.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 127
3 free questions a day, no accountHistory
- Read for the first time and referred to the House Committee on Health
- Pending Committee Action in House of Origin (Health)
- Filed
Sponsors
- Brown (C) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 127 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 127 freeOr ask your AI assistant about HB 127 directly:
Add to Claude, ChatGPT or Cursor